Join Growin Stock Community!

雷虎生6493.TW Overview

TW StockBiotech. & Medical
(No presentation for 6493)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

雷虎生（6493）Overall Performance

雷虎生（6493）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

雷虎生（6493） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

雷虎生（6493）Key Information

雷虎生（6493）Profile

Ttbio Corp. manufactures, sells, and maintains medical devices under the TTBIO brand name in Taiwan and internationally. The company offers high and low speed hand piece products, dental spare parts, service rotors, maintenance units, and electric hand piece systems. It also provides precision machined parts and components to various industries, including medical, automotive, aerospace, security, computer components, maintenance parts, and custom machining. The company was founded in 2012 and is based in Taichung, Taiwan.

雷虎生（6493）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.22
PE Ratio (TTM)
130.46
Forward PE
-
PS Ratio (TTM)
1.19
PB Ratio
2.95
Price-to-FCF
9.50
METRIC
VALUE
vs. INDUSTRY
Gross Margin
22.52%
Net Margin
0.91%
Revenue Growth (YoY)
-1.88%
Profit Growth (YoY)
-24.84%
3-Year Revenue Growth
17.26%
3-Year Profit Growth
-6.07%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.22
PE Ratio (TTM)
130.46
Forward PE
-
PS Ratio (TTM)
1.19
PB Ratio
2.95
Price-to-FCF
9.50
Gross Margin
22.52%
Net Margin
0.91%
Revenue Growth (YoY)
-1.88%
Profit Growth (YoY)
-24.84%
3-Year Revenue Growth
17.26%
3-Year Profit Growth
-6.07%
default symbol

6493

雷虎生

28.15D

-3.02%

(-0.03)

  • When is 6493's latest earnings report released?

    The most recent financial report for 雷虎生 (6493) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 6493's short-term business performance and financial health. For the latest updates on 6493's earnings releases, visit this page regularly.

  • How much cash does 6493 have?

    At the end of the period, 雷虎生 (6493) held Total Cash and Cash Equivalents of 100.83M, accounting for 0.16 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 6493 go with three margins increasing?

    In the latest report, 雷虎生 (6493) did not achieve the “three margins increasing” benchmark, with a gross margin of 20.44%%, operating margin of 1.26%%, and net margin of -1.23%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 6493's profit trajectory and future growth potential.